Medifast (NYSE:MED – Get Free Report) issued an update on its first quarter earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $0.25-0.95 for the period, compared to the consensus estimate of $1.50. The company issued revenue guidance of $155-175 million, compared to the consensus revenue estimate of $205.79 million. […]
Medifast (NYSE:MED – Get Free Report) issued its quarterly earnings results on Tuesday. The specialty retailer reported $1.09 EPS for the quarter, topping the consensus estimate of $0.99 by $0.10, Briefing.com reports. The company had revenue of $191.02 million for the quarter, compared to the consensus estimate of $184.17 million. Medifast had a return on […]
Principal Financial Group Inc. trimmed its holdings in shares of Medifast, Inc. (NYSE:MED – Free Report) by 2.6% in the third quarter, Holdings Channel.com reports. The firm owned 64,159 shares of the specialty retailer’s stock after selling 1,685 shares during the quarter. Principal Financial Group Inc.’s holdings in Medifast were worth $4,802,000 as of its […]
Ingalls & Snyder LLC lowered its position in shares of Medifast, Inc. (NYSE:MED – Free Report) by 0.7% in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 32,485 shares of the specialty retailer’s stock after selling 220 shares during the quarter. Ingalls & Snyder […]
Ingalls & Snyder LLC trimmed its holdings in Medifast, Inc. (NYSE:MED – Free Report) by 0.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 32,485 shares of the specialty retailer’s stock after selling 220 shares during the quarter. Ingalls & Snyder LLC’s holdings in […]